‘Monkey dust’ could be reclassified as Class A drug
The UK Government is considering reclassifying the drug ‘monkey dust’ from Class B to A, it has been announced.
GB Drugs News
News Archive
Cannabis use triggers one in three schizophrenia cases among young men
Young men regularly using cannabis are at significant risk of developing schizophrenia, a new study has shown.
